Antibe Therapeutics (ATE) Stock Chart & Stock Price History → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free ATE Stock Alerts C$0.30 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Antibe Therapeutics Stock Price Performance5 Day PerformanceN/A1 Month Performance-32.18%3 Month Performance-67.93%6 Month Performance-51.64%Year-To-Date Performance-68.28%1 Year Performance-45.37% Receive ATE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry Research“Retirement Secret” Showed 995% Gain Last Time We Shared ItCentral Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars). ATE Stock Chart for Friday, April, 26, 2024 ATE Chart by TradingView Antibe Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/10/2024C$0.30C$0.30C$0.35C$0.26167,044 shsC$15.54 million04/09/2024C$0.30C$0.30C$0.35C$0.26167,044 shsC$15.54 million04/08/2024C$0.26C$0.30+13.46%C$0.35C$0.26167,044 shsC$15.54 million04/05/2024C$0.30C$0.26-11.86%C$0.30C$0.25137,518 shsC$13.69 million04/04/2024C$0.27C$0.30+11.32%C$0.34C$0.26160,906 shsC$15.54 million04/03/2024C$0.19C$0.27+43.24%C$0.30C$0.20469,101 shsC$13.96 million Get the Latest News and Ratings for ATE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/02/2024C$0.17C$0.19+12.12%C$0.19C$0.17721,169 shsC$9.74 million04/01/2024C$0.45C$0.17-63.33%C$0.24C$0.151.63 million shsC$8.69 million03/29/2024C$0.45C$0.45C$0.47C$0.4351,300 shsC$23.70 million03/28/2024C$0.43C$0.45+4.65%C$0.47C$0.4351,300 shsC$23.70 million03/27/2024C$0.44C$0.43-1.15%C$0.44C$0.437,128 shsC$22.65 million03/26/2024C$0.43C$0.44+1.16%C$0.44C$0.4323,174 shsC$22.91 million03/25/2024C$0.43C$0.43+1.18%C$0.44C$0.436,415 shsC$22.65 million03/22/2024C$0.43C$0.43C$0.47C$0.4267,444 shsC$22.39 million03/21/2024C$0.41C$0.43+4.94%C$0.43C$0.4141,445 shsC$22.39 million03/20/2024C$0.41C$0.41C$0.43C$0.4076,235 shsC$21.33 million03/19/2024C$0.43C$0.41-4.71%C$0.44C$0.40126,214 shsC$21.33 million03/18/2024C$0.43C$0.43-1.16%C$0.44C$0.4316,000 shsC$22.39 million03/15/2024C$0.46C$0.43-5.49%C$0.45C$0.4364,000 shsC$22.65 million03/14/2024C$0.48C$0.46-4.21%C$0.49C$0.4467,065 shsC$23.97 million03/13/2024C$0.46C$0.48+3.26%C$0.49C$0.44106,943 shsC$25.02 million03/12/2024C$0.43C$0.46+8.24%C$0.47C$0.4544,233 shsC$24.23 million03/11/2024C$0.45C$0.43-5.56%C$0.47C$0.4388,421 shsC$22.39 million03/08/2024C$0.52C$0.45-13.46%C$0.53C$0.45251,210 shsC$23.70 million03/07/2024C$0.51C$0.52+1.96%C$0.56C$0.50178,477 shsC$27.39 million03/06/2024C$0.53C$0.51-3.77%C$0.61C$0.40571,296 shsC$26.86 million03/05/2024C$0.50C$0.53+6.00%C$0.56C$0.51245,570 shsC$27.92 million03/04/2024C$0.97C$0.50-48.45%C$0.59C$0.301.63 million shsC$26.34 million03/01/2024C$0.96C$0.97+1.04%C$1.02C$0.9758,951 shsC$51.09 million02/29/2024C$0.97C$0.96-1.03%C$0.99C$0.9572,122 shsC$50.56 million02/28/2024C$0.99C$0.97-2.02%C$0.99C$0.9650,683 shsC$51.09 million02/27/2024C$1.01C$0.99-1.98%C$1.03C$0.9981,747 shsC$52.14 million02/26/2024C$1.03C$1.01-1.94%C$1.05C$1.0143,248 shsC$53.20 million02/23/2024C$0.98C$1.03+5.10%C$1.08C$0.95174,626 shsC$54.25 million02/22/2024C$0.96C$0.98+2.08%C$0.99C$0.9770,600 shsC$51.62 million02/21/2024C$0.95C$0.96+1.05%C$0.97C$0.9519,500 shsC$50.56 million02/20/2024C$0.93C$0.95+2.15%C$0.99C$0.9463,511 shsC$50.04 million02/19/2024C$0.93C$0.93C$0.97C$0.9039,730 shsC$48.96 million02/16/2024C$0.92C$0.93+1.09%C$0.97C$0.9039,731 shsC$48.96 million02/15/2024C$0.90C$0.92+2.22%C$0.94C$0.8885,698 shsC$48.43 million“Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers.Find out why right here (and see what you can do to get in too with just a few dollars).02/14/2024C$0.89C$0.90+1.12%C$0.91C$0.8838,225 shsC$47.38 million02/13/2024C$0.93C$0.89-4.30%C$0.91C$0.8931,500 shsC$46.85 million02/12/2024C$0.92C$0.93+1.09%C$0.94C$0.8972,783 shsC$48.96 million02/09/2024C$0.95C$0.92-3.16%C$0.95C$0.9140,763 shsC$48.43 million02/08/2024C$0.97C$0.95-2.06%C$0.97C$0.9560,000 shsC$50.01 million02/07/2024C$0.98C$0.97-1.02%C$1.00C$0.9544,922 shsC$51.06 million02/06/2024C$1.00C$0.98-2.00%C$1.00C$0.9819,955 shsC$51.59 million02/05/2024C$0.95C$1.00+5.26%C$1.00C$0.9278,960 shsC$52.64 million02/02/2024C$0.99C$0.95-4.04%C$1.00C$0.9526,940 shsC$50.01 million02/01/2024C$1.01C$0.99-1.98%C$1.01C$0.9822,975 shsC$52.11 million01/31/2024C$1.02C$1.01-0.98%C$1.03C$1.0116,700 shsC$53.17 million01/30/2024C$0.99C$1.02+3.03%C$1.02C$1.0030,375 shsC$53.69 million01/29/2024C$0.92C$0.99+7.61%C$1.00C$0.9140,876 shsC$52.11 million01/26/2024C$0.91C$0.92+1.10%C$0.96C$0.9116,900 shsC$48.43 million01/25/2024C$0.92C$0.91-1.09%C$0.92C$0.9022,370 shsC$47.90 million Related Companies: Sirona Biochem Stock Price Chart Resverlogix Stock Price Chart Aeterna Zentaris Stock Price Chart Kane Biotech Stock Price Chart Ceapro Stock Price Chart Quest PharmaTech Stock Price Chart Innovotech Stock Price Chart Hemostemix Stock Price Chart Covalon Technologies Stock Price Chart Aptose Biosciences Stock Price Chart Receive ATE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Antibe Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:ATE) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsI’m afraid WWIII is a very real possibility Porter & CompanyThe Next Nvidia?InvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Antibe Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.